journal article·2021-06-09

Isolating Nanoparticles from Complex Biological Media by Immunoprecipitation

Youcef Chakib Hacene, Alexis Loiseau, Vanessa Dos Passos Maio, Philippe Grenier, Elodie Boisselier, Nicolas Bertrand

Nano Letters· Volume 21· Issue 11
Publisher page

Abstract

Polyethylene glycol (PEG) is considered the gold standard to prepare long circulating nanoparticles. The hydrophilic layer that sterically protects PEGylated nanomedicines also impedes their separation from biological media. In this study, we describe an immunoprecipitation method using AntiPEG antibodies cross-linked to magnetic beads to extract three types of radiolabeled PEGylated systems: polymeric nanoparticles, liposomes, and therapeutic proteins. The potential of the method is emphasized by isolating these systems after in vivo administration and ex vivo incubation in human biological fluids. Immunoprecipitation also allows a unique perspective on the size distribution of nanoparticles in the bloodstream after intravenous and intraperitoneal administrations. Further, we highlight the potential of the approach to inform on nanomaterial-associated drug in plasma as well as help characterize the protein corona. Altogether, we believe this method answers an unmet need in nanomedicine research and will contribute a fresh perspective on the interactions of nanomedicines with biological systems.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Characterization and Applications of Magnetic Nanoparticles

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Pharmacy, CHU de Quebec Research Center, Université Laval, CHUL, 2705 Laurier Blvd, Québec G1 V 4G2, Canada

Faculty of Medicine, Department of Ophthalmology, CHU de Québec Research Center, Université Laval, Hôpital du Saint-Sacrement, CUO-Recherche, 1050, chemin Sainte-Foy, Québec, G1S 4L8, Canada

Funding

Fonds de Recherche du Qu??bec - Sant?? · Canada Foundation for Innovation · Fonds de Recherche du Qu??bec - Nature et Technologies · Natural Sciences and Engineering Research Council of Canada

References (35)

Show source-provided references
1. 10.1634/theoncologist.2019-078510.1634/theoncologist.2019-0785 ↗
2. 10.1038/s41565-019-0591-y10.1038/s41565-019-0591-y ↗
3. 10.1056/NEJMoa202248310.1056/NEJMoa2022483 ↗
4. 10.1016/j.apsb.2021.02.02210.1016/j.apsb.2021.02.022 ↗
5. 10.1021/acs.bioconjchem.0c0036610.1021/acs.bioconjchem.0c00366 ↗
6. 10.1039/D0NR04100A10.1039/D0NR04100A ↗
7. 10.1038/nprot.2014.13910.1038/nprot.2014.139 ↗
8. 10.1038/s41565-018-0344-310.1038/s41565-018-0344-3 ↗
9. 10.1073/pnas.060858210410.1073/pnas.0608582104 ↗
10. 10.1016/j.jconrel.2018.08.02210.1016/j.jconrel.2018.08.022 ↗
11. 10.1038/s41467-017-00600-w10.1038/s41467-017-00600-w ↗
12. 10.1002/wnan.146710.1002/wnan.1467 ↗
13. 10.1007/s10337-014-2677-x10.1007/s10337-014-2677-x ↗
14. 10.3390/ijms16081929110.3390/ijms160819291 ↗
15. 10.1007/s13346-020-00812-610.1007/s13346-020-00812-6 ↗
16. 10.1007/s11095-020-02877-x10.1007/s11095-020-02877-x ↗
17. 10.1038/nnano.2016.26910.1038/nnano.2016.269 ↗
18. 10.1002/0471140864.ps0908s1810.1002/0471140864.ps0908s18 ↗
19. 10.3390/molecules2416292910.3390/molecules24162929 ↗
20. 10.1016/S0021-9258(17)40292-410.1016/S0021-9258(17)40292-4 ↗
21. 10.1016/0005-2736(91)90246-510.1016/0005-2736(91)90246-5 ↗
22. 10.1126/science.812824510.1126/science.8128245 ↗
23. 10.1021/nl900031y10.1021/nl900031y ↗
24. 10.1016/j.addr.2015.09.01210.1016/j.addr.2015.09.012 ↗
25. Gabizon A. · Cancer Res. · 1994 · 54 · 987
26. 10.1080/14656566.2016.118364610.1080/14656566.2016.1183646 ↗
27. 10.1007/s40123-014-0021-z10.1007/s40123-014-0021-z ↗
28. 10.1016/j.cell.2020.07.02410.1016/j.cell.2020.07.024 ↗
29. 10.1016/j.addr.2020.12.01410.1016/j.addr.2020.12.014 ↗
30. 10.1007/BF0036826310.1007/BF00368263 ↗
31. 10.1021/acs.analchem.7b0286310.1021/acs.analchem.7b02863 ↗
32. 10.1038/ncomms876510.1038/ncomms8765 ↗
33. 10.1126/scitranslmed.300913510.1126/scitranslmed.3009135 ↗
34. Center for Drug Evaluation and Research (CDER). · 2017
35. 10.1074/mcp.M500061-MCP20010.1074/mcp.M500061-MCP200 ↗